author-photo

Lionel Bosquée

Université catholique de Louvain

46

Papers

1010

Citations

Citation Trend

Filter By

Papers (32) Sort By

Journal Conference Others

[Central nervous system tuberculosis : don't miss the diagnosis !]

2020 Revue médicale de Liège
Show All
- Source
- Cite
- Save
Citations (0)
Central nervous system tuberculosis, one of the most challenging of infections

2019
Show All
- Source
- Cite
- Save
Citations (0)
Headaches after a recent pregnancy need an MRI to rule out cerebral thrombosis

2019
Show All
- Source
- Cite
- Save
Citations (0)
An unusual cause of portal hypertension in a cirrhotic patient

2019
Show All
- Source
- Cite
- Save
Citations (0)
GAIN-(L): Efficacy and biomarker findings of RG7160 (GA201), a novel, dual-acting monoclonal antibody (mAb) designed to enhance antibody-dependent cellular cytotoxicity (ADCC), in combination with first-line cisplatin and pemetrexed in metastatic nonsquamous NSCLC.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
START: A phase III study of L-BLP25 cancer immunotherapy for unresectable stage III non-small cell lung cancer.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (51)
An Open-Label, Multicenter, Randomized, Phase II Study of Cisplatin and Pemetrexed With or Without Cixutumumab (IMC-A12) as a First-Line Therapy in Patients With Advanced Nonsquamous Non-Small Cell Lung Cancer

2017 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (16)
Prospective Evaluation of First-Line Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Carrying an Activating EGFR Mutation: A Multicenter Academic Phase II Study in Caucasian Patients (FIELT)

2016 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (16)
Thrombo-embolic events in cancer patients with impaired renal function

2015
Show All
- Source
- Cite
- Save
Citations (0)
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

2014 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (328)